Skip to main content

Advertisement

SpringerLink
Log in

Review of Physical Urticarias and Testing Methods

  • Allergic Skin Diseases (L Fonacier, Section Editor)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This review aims to update the information available on the prevalence, clinical picture, diagnostic methods, and treatment of urticarias induced by external physical stimuli.

Recent Findings

Physical urticarias are present in up to 5% of the general population, and in 10 to 50% of patients with chronic urticaria. Recent investigations have provided evidence that the presence of physical urticaria alone or when comorbid with chronic spontaneous urticaria is associated with a worse prognosis and duration.

Summary

Most frequent subtypes of physical urticaria are dermographism and delayed pressure urticaria. The diagnosis is established through specific provocation tests and the management encompasses avoidance measures, pharmacologic therapy with nonsedating antihistamines, and alternative medications in refractory cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul Latiff AH, Mathelier-Fusade P, Metz M, Nast A, Saini SS, Sánchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Maurer M; European Academy of Allergy and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014: 69: 868–87. Important because this is the current internationally accepted document helpful for the diagnosis and treatment of chronic spontaneous and inducible urticarias.

  2. • Magerl M, Altrichter S, Borzova E, Giménez-Arnau A, Grattan CE, Lawlor F, et al. The definition, diagnostic testing, and management of chronic inducible urticarias—the EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision. Allergy. 2016;71:780–802. An updated review of all forms of inducible urticarias, especially helpful as a resource on validated diagnostic methods for such diseases

    Article  CAS  PubMed  Google Scholar 

  3. Weller K, Altrichter S, Ardelean E, Krause K, Magerl M, Metz M, et al. Chronic urticaria. Prevalence, course, prognostic factors and impact. Hautarzt. 2010;61:750–7.

    Article  CAS  PubMed  Google Scholar 

  4. Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Subtypes of chronic urticaria in patients attending allergy clinics in Venezuela. Eur Ann Allergy Clin Immunol. 2014;46:210–5.

    PubMed  Google Scholar 

  5. • Maurer M, Weller K, Bindslev-Jensen C, Giménez-Arnau A, Bousquet PJ, Bousquet J, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy. 2011;66:317–30. Here authors indicate areas of uncertain knowledge for understanding chronic urticaria that need further investigation

    Article  CAS  PubMed  Google Scholar 

  6. Hiragun M, Hiragun T, Mihara S, Akita T, Tanaka J, Hide M. Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine. Allergy. 2013;68:229–35.

    Article  CAS  PubMed  Google Scholar 

  7. • Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A, González-Aveledo L, Maurer M. Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 2017; doi:10.1111/jdv. 14221. This paper highlights that the presence of physical urticaria confers a worse prognosis for patients with urticaria

  8. Kozel MM, Mekkes JR, Bossuyt PM, Bos JD. Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol. 2001;45:387–91.

    Article  CAS  PubMed  Google Scholar 

  9. Dice JP. Physical urticaria. Immunol Allergy Clin N Am. 2004;24:225–46.

    Article  Google Scholar 

  10. Trevisonno J, Balram B, Netchiporouk E, Ben-Shoshan M. Physical urticaria: review on classification, triggers and management with special focus on prevalence including a meta-analysis. Postgrad Med. 2015;127:565–70.

    Article  PubMed  Google Scholar 

  11. Barlow RJ, Warburton F, Watson K, Black AK, Greaves MW. Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria. J Am Acad Dermatol. 1993;29:954–8.

    Article  CAS  PubMed  Google Scholar 

  12. Katsarou-Katsari A, Makris M, Lagogianni E, Gregoriou S, Theoharides T, Kalogeromitros D. Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study. J Eur Acad Dermatol Venereol. 2008;22:1405–11.

    Article  CAS  PubMed  Google Scholar 

  13. Chong WS, Khoo SW. Solar urticaria in Singapore: an uncommon photodermatosis seen in a tertiary dermatology center over a 10-year period. Photodermatol Photoimmunol Photomed. 2004;20:101–4.

    Article  PubMed  Google Scholar 

  14. Carrillo DC, Sánchez-Borges M, García E, Egea E, Serrano CD. Omalizumab vs placebo in the management of chronic idiopathic urticaria: a systematic review. World Allergy Organ J. 2014;7:72.

    Article  PubMed  PubMed Central  Google Scholar 

  15. •• Sánchez-Borges M, Asero R, Ansotegui IJ, Baiardini I, Bernstein JA, Canonica GW, Gower R, Kahn DA, Kaplan AP, Katelaris C, Maurer M, Park HS, Potter P, Saini S, Tassinari P, Tedeschi A, Ye YM, Zuberbier T; WAO Scientific and Clinical Issues Council. Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J. 2012: 5: 125–47. A review of chronic urticaria with recommendations for its treatment according to evidence based medicine.

  16. Leigh IM, Ramsay CA, Calnan CD. Cold urticaria—‘desensitisation’. Trans St Johns Hosp Dermatol Soc. 1979;60:40–2.

    Google Scholar 

  17. Black AK, Sibbald RG, Greaves MW. Cold urticaria treated by induction of tolerance. Lancet. 1979;2:964.

    Article  CAS  PubMed  Google Scholar 

  18. Leigh IM, Ramsay CA. Localized heat urticaria treated by inducing tolerance to heat. Br J Dermatol. 1975;92:191–4.

    Article  CAS  PubMed  Google Scholar 

  19. Ramsay CA. Solar urticaria treatment by inducing tolerance to artificial radiation and natural light. Arch Dermatol. 1977;113:1222–5.

    Article  CAS  PubMed  Google Scholar 

  20. Soter NA, Wasserman SI. Physical urticaria/angioedema: an experimental model of mast cell activation in humans. J Allergy Clin Immunol. 1980;66:358–65.

    Article  CAS  PubMed  Google Scholar 

  21. Krause K, Ardelean E, Kessler B, Magerl M, Metz M, Siebenhaar F, et al. Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy. Allergy. 2010;65:1494–5.

    Article  CAS  PubMed  Google Scholar 

  22. Metz M, Altrichter S, Ardelean E, Kessler B, Krause K, Magerl M, et al. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol. 2011;154:177–80.

    Article  CAS  PubMed  Google Scholar 

  23. Toda S, Takahagi S, Mihara S, Hide M. Six cases of antihistamine-resistant dermographic urticaria treated with oral ciclosporin. Allergol Int. 2011;60:547–50.

    Article  CAS  PubMed  Google Scholar 

  24. Borzova E, Rutherford A, Konstantinou GN, Leslie KS, Grattan CE. Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study. J Am Acad Dermatol. 2008;59:752–7.

    Article  PubMed  Google Scholar 

  25. Johnsson M, Falk ES, Volden G. UVB treatment of factitious urticaria. Photo-Dermatology. 1987;4:302–4.

    CAS  PubMed  Google Scholar 

  26. Barlow RJ, Ross EL, MacDonald D, Black AK, Greaves MW. Adhesion molecule expression and the inflammatory cell infiltrate in delayed pressure urticaria. Br J Dermatol. 1994;131:341–7.

    Article  CAS  PubMed  Google Scholar 

  27. Nettis E, Colanardi MC, Soccio AL, Ferrannini A, Vacca A. Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study. Br J Dermatol. 2006;155:1279–82.

    Article  CAS  PubMed  Google Scholar 

  28. Rodríguez-Rodríguez M, Antolin-Amerigo D, Barbarroja-Escudero J, Sánchez-González MJ, Alvarez-Mon M. Successful treatment of severe delayed pressure angio-oedema with omalizumab. Allergol Immunopathol. 2014;42:78–80.

    Article  Google Scholar 

  29. Bindslev-Jensen C, Skov PS. Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy. 2010;65:138–9.

    Article  CAS  PubMed  Google Scholar 

  30. Grundmann SA, Kiefer S, Luger TA, Brehler R. Delayed pressure urticaria—dapsone heading for first-line therapy? J Dtsch Dermatol Ges. 2011;9:908–12.

    PubMed  Google Scholar 

  31. Swerlick RA, Puar N. Delayed pressure urticaria: response to treatment with sulfasalazine in a case series of seventeen patients. Dermatol Ther. 2015;28:318–22.

    Article  PubMed  Google Scholar 

  32. Magerl M, Philipp S, Manasterski M, Friedrich M, Maurer M. Successful treatment of delayed pressure urticaria with anti-TNF-alpha. J Allergy Clin Immunol. 2007;119:752–4.

    Article  PubMed  Google Scholar 

  33. Kalogeromitros D, Kempuraj D, Katsarou-Katsari A, Gregoriou S, Makris M, Boucher W, et al. Theophylline as “add-on” therapy in patients with delayed pressure urticaria: a prospective self-controlled study. Int J Immunopathol Pharmacol. 2005;18:595–602.

    Article  CAS  PubMed  Google Scholar 

  34. Wanderer AA, Grandel KE, Wasserman SI, Farr RS. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol. 1986;78:417–23.

    Article  CAS  PubMed  Google Scholar 

  35. Hochstadter EF, Ben-Shoshan M. Cold-induced urticaria: challenges in diagnosis and management. BMJ Case Rep. 2013; doi:10.1136/bcr-2013-010441.

  36. Kaplan AP, Gray L, Shaff RE, Horakova Z, Beaven MA. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol. 1975;55:394–402.

    Article  CAS  PubMed  Google Scholar 

  37. Stankovic K, Grateau G. Auto inflammatory syndromes: diagnosis and treatment. Joint Bone Spine. 2007;74:544–50.

    Article  PubMed  Google Scholar 

  38. Ombrello MJ, Remmers EF, Sun G, Freeman AF, Datta S, Torabi-Parizi P, et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. New Engl J Med. 2012;366:330–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Kolivras A, Theunis A, Ferster A, Lipsker D, Sass U, Dussart A, et al. Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement. J Cutan Pathol. 2011;38:202–8.

    Article  PubMed  Google Scholar 

  40. Aróstegui JI, Aldea A, Modesto C, Rua MJ, Argüelles F, González-Enseñat MA, et al. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Arthritis Rheum. 2004;50:4045–50.

    Article  PubMed  Google Scholar 

  41. Wanderer AA, Grandel KE, Wasserman SI, Farr RS. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. Immunol Allergy Clin N Am. 2004;24:259–86.

    Article  Google Scholar 

  42. Hoffman HM, Wanderer AA, Broide DH. Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol. 2001;108:615–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Martinez-Escala ME, Curto-Barredo L, Carnero L, Pujol RM, Giménez-Arnau AM. Temperature thresholds in assessment of the clinical course of acquired cold contact urticaria: a prospective observational one-year study. Acta Derm Venereol. 2015;95:278–82.

    Article  PubMed  Google Scholar 

  44. Magerl M, Abajian M, Krause K, Altrichter S, Siebenhaar F, Church MK. An improved Peltier effect-based instrument for critical temperature threshold measurement in cold- and heat-induced urticaria. J Eur Acad Dermatol Venereol. 2015;29:2043–5.

    Article  CAS  PubMed  Google Scholar 

  45. • Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol. 2009;123:672–9. A study showing improvement of cold urticaria with increased doses of nonsedating antihistamines

    Article  CAS  PubMed  Google Scholar 

  46. • Krause K, Spohr A, Zuberbier T, Church MK, Maurer M. Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy. 2013;68:921–8. Confirmation of the usefulness of increased doses of bilastine in patients with acquired cold urticaria

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol. 2006;117:1415–8.

    Article  CAS  PubMed  Google Scholar 

  48. Möller A, Henning M, Zuberbier T, Czarnetzki-Henz BM. Epidemiology and clinical aspects of cold urticaria. Hautarzt. 1996;47:510–4.

    Article  PubMed  Google Scholar 

  49. Bodar EJ, Simon A, de Visser M, van der Meer JW. Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra). Neth J Med. 2009;67:302–5.

    CAS  PubMed  Google Scholar 

  50. Gualdi G, Monari P, Rossi MT, Crotti S, Calzavara-Pinton PG. Successful treatment of systemic cold contact urticaria with etanercept in a patient with psoriasis. Br J Dermatol. 2012;166:1373–4.

    Article  CAS  PubMed  Google Scholar 

  51. Bentley-Phillips CB, Black AK, Greaves MW. Induced tolerance in cold urticaria caused by cold-evoked histamine release. Lancet. 1976;2:63–6.

    Article  CAS  PubMed  Google Scholar 

  52. Kring Tannert L, Stahl Skov P, Bjerremann Jensen L, Maurer M, Bindslev-Jensen C. Cold urticaria patients exhibit normal skin levels of functional mast cells and histamine after tolerance induction. Dermatology. 2012;224:101–5.

    Article  PubMed  Google Scholar 

  53. Bullerkotte U, Wieczorek D, Kapp A, Wedi B. Effective treatment of refractory severe heat urticaria with omalizumab. Allergy. 2010;65:931–2.

    Article  CAS  PubMed  Google Scholar 

  54. Carballada F, Nuñez R, Martin-Lazaro J, Juárez Y, Castiñeira I, Carballada F, et al. Omalizumab treatment in 2 cases of refractory heat urticaria. J Investig Allergy Clin Immunol. 2013;23:519–21.

    CAS  Google Scholar 

  55. Farr PM. Solar urticaria. Br J Dermatol. 2000;142:4–5.

    Article  CAS  PubMed  Google Scholar 

  56. Botto NC, Warshaw EM. Solar urticaria. J Am Acad Dermatol. 2008;59:909–20.

    Article  PubMed  Google Scholar 

  57. Duchini G, Bäumler W, Bircher AJ, Scherer K. Failure of omalizumab (Xolair®) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light. Photodermatol Photoimmunol Photomed. 2011;27:336–7.

    Article  CAS  PubMed  Google Scholar 

  58. Arasi S, Crisafulli G, Caminiti L, Guarneri F, Aversa T, Porcaro F, et al. Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria. Pediatric Allergy Immunol. 2015;26:583–5.

    Article  Google Scholar 

  59. Levi A, Tal Y, Dranitzki Z, Shalit M, Enk CD. Successful omalizumab treatment of severe solar urticaria in a 6-year-old child. Pediatric Allergy Immunol. 2015;26:588–90.

    Article  CAS  Google Scholar 

  60. Güzelbey O, Ardelean E, Magerl M, Zuberbier T, Maurer M, Metz M. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy. 2008;63:1563–5.

    Article  PubMed  Google Scholar 

  61. Waibel KH, Reese DA, Hamilton RG, Devillez RL. Partial improvement of solar urticaria after omalizumab. J Allergy Clin Immunol. 2010;125:490–1.

    Article  CAS  PubMed  Google Scholar 

  62. Edström DW, Ros AM. Cyclosporin A therapy for severe solar urticaria. Photodermatol Photoimmunol Photomed. 1997;13:61–3.

    Article  PubMed  Google Scholar 

  63. Puech-Plottova I, Michel JL, Rouchouse B, Perrot JL, Dzviga C, Cambazard F. Solar urticaria: one case treated by intravenous immunoglobulin. Ann Dermatol Venereol. 2000;127:831–5.

    CAS  PubMed  Google Scholar 

  64. Haylett AK, Nie Z, Brownrigg M, Taylor R, Rhodes LE. Systemic photoprotection in solar urticaria with α-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-α-MSH. Br J Dermatol. 2011;164:407–14.

    Article  CAS  PubMed  Google Scholar 

  65. Roelandts R. Pre-PUVA UVA desensitization for solar urticaria. Photo-Dermatology. 1985;2:174–6.

    CAS  PubMed  Google Scholar 

  66. Hudson-Peacock MJ, Farr PM, Diffey BL, Goodship TH. Combined treatment of solar urticaria with plasmapheresis and PUVA. Br J Dermatol. 1993;128:440–2.

    Article  CAS  PubMed  Google Scholar 

  67. Duschet P, Leyen P, Schwarz T, Höcker P, Greiter J, Gschnait F. Solar urticaria: treatment by plasmapheresis. J Am Acad Dermatol. 1986;15:712–3.

    Article  CAS  PubMed  Google Scholar 

  68. Roelandts R. Diagnosis and treatment of solar urticaria. Dermatol Ther. 2003;16:52–6.

    Article  PubMed  Google Scholar 

  69. Beissert S, Ständer H, Schwarz T. UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol. 2000;42:1030–2.

    Article  CAS  PubMed  Google Scholar 

  70. Hölzle E, Hofmann C, Plewig G. PUVA-treatment for solar urticaria and persistent light reaction. Arch Dermatol Res. 1980;269:87–91.

    Article  PubMed  Google Scholar 

  71. Epstein PA, Kidd KK. Dermo-distortive urticaria: an autosomal dominant dermatologic disorder. Am J Med Genet. 1981;9:307–15.

    Article  CAS  PubMed  Google Scholar 

  72. Pressler A, Grosber M, Halle M, Ring J, Brockow K. Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio-oedema. Clin Exp Dermatol. 2013;38:151–3.

    Article  CAS  PubMed  Google Scholar 

  73. Ting S, Reimann BE, Rauls DO, Mansfield LE. Nonfamilial, vibration-induced angioedema. J Allergy Clin Immunol. 1983;71:546–51.

    Article  CAS  PubMed  Google Scholar 

  74. Fukunaga A, Bito T, Tsuru K, Oohashi A, Yu X, Ichihashi M, et al. Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes. J Allergy Clin Immunol. 2005;116:397–402.

    Article  CAS  PubMed  Google Scholar 

  75. Metz M, Maurer M. Omalizumab in chronic urticaria. Curr Opin Allergy Clin Immunol. 2012;12:406–11.

    Article  CAS  PubMed  Google Scholar 

  76. Seize MB, Ianhez M, de Souza PK, Rotta O, Cestari CS. Familial aquagenic urticaria: report of two cases and literatura review. An Bras Dermatol. 2009;84:530–3.

    Article  PubMed  Google Scholar 

  77. Parker RK, Crowe MJ, Guin JD. Aquagenic urticaria. Cutis. 1992;50:283–4.

    CAS  PubMed  Google Scholar 

  78. Martinez-Escribano JA, Quecedo E, De la Cuadra J, Frias J, Sanchez-Pedreno P, Aliaga A. Treatment of aquagenic urticaria with PUVA and astemizole. J Am Acad Dermatol. 1997;36:118–9.

    Article  CAS  PubMed  Google Scholar 

  79. Bayle P, Gadroy A, Messer L, Basex J. Localized aquagenic urticaria: efficacy of a barrier cream. Contact Dermatitis. 2003;49:160–1.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Allergy and Clinical Immunology Department, Centro Médico Docente La Trinidad, Caracas, Venezuela

    Mario Sánchez-Borges, Fernan Caballero-Fonseca & Arnaldo Capriles-Hulett

  2. Allergy and Clinical Immunology Service, Clínica El Avila, 6a transversal Urb. Altamira, piso 8, consultorio 803, Caracas, 1060, Venezuela

    Mario Sánchez-Borges

  3. Dermatology Service, Centro Médico de Caracas, Caracas, Venezuela

    Luis González-Aveledo

  4. Allergy and Immunology Service, Centro Médico de Caracas, Caracas, Venezuela

    Fernan Caballero-Fonseca & Arnaldo Capriles-Hulett

Authors
  1. Mario Sánchez-Borges
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luis González-Aveledo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fernan Caballero-Fonseca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arnaldo Capriles-Hulett
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mario Sánchez-Borges.

Additional information

This article is part of the Topical Collection on Allergic Skin Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sánchez-Borges, M., González-Aveledo, L., Caballero-Fonseca, F. et al. Review of Physical Urticarias and Testing Methods. Curr Allergy Asthma Rep 17, 51 (2017). https://doi.org/10.1007/s11882-017-0722-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11882-017-0722-1

Keywords

Search

Navigation